FIT Biotech

FIT Biotech is an innovative medical biotechnology company engaged in the development and commercialisation of its proprietary Gene Transport Unit (GTU®) technology and GTU® product applications in DNA vaccination as well as in immuno- and gene therapies.

News and Events

Press Release 19.7.2010 / July-19-2010

Phase II Data From FIT Biotech’s HIV Immunotherapy Show Reduction in Viral Load and Increase in CD4 Cell Count
Read more

Lehdistötiedote 19.7.2010 / July-19-2010

Lupaavia tuloksia HIV-positiivisten hoitoon uuden DNA-rokoteteknologian ansiosta
Read more

Press Release 30.6.2010 / June-30-2010

EU-rahoitusta suositeltu FIT Biotechin tuberkuloosirokotehankkeelle
Read more

Press Release 29.3.2010 / March-29-2010

Finnish vaccine technology plays key role in development of a new tuberculosis vaccine
Read more

Lehdistötiedote 29.3.2010 / March-29-2010

Suomalainen rokoteteknologia avainasemassa tehokkaamman tuberkuloosirokotteen kehitystyössä
Lue lisää